ArticleJournal of inflammation research2025
Time-Dependent Mortality Predictors in Primary Sjögren's Syndrome: C-Reactive Protein for Early Risk and Age for Late Outcomes.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Expression characteristics of C-reactive protein in autoimmune diseases and their complications.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To identify risk factors for near-term and long-term death in patients with primary Sjogren's syndrome (pSS). Patients and Methods: This ambispective cohort study included all patients with pSS treated at China-Japan Friendship Hospital between 2013 and 2023. The time-dependent Cox regression analysis was used for statistical analysis of risk factors, with 3 months and 60 months as the cut-off time points and all-cause death as the primary endpoint. Results: Among the 1252 included patients, 138 patients had died by the end of follow-up (11.0%). Age at diagnosis, C-reactive protein (CRP) levels and total bilirubin (TBIL) were time-dependent risk factors for mortality. Within 3 months of follow-up, age > 65 years had no effect on mortality, but after 3 months of follow-up, the mortality risk in patients aged > 65 years increased over time (HR 3.97, 95% CI 2.57-6.13; HR 16.63, 95% CI 5.53-50.03). CRP >6.5 mg/L increased the risk of mortality within 3 months (HR=11.45, 95% CI 2.52-51.95), followed by 3-60 months (HR=2.94, 95% CI 1.94-4.45), but did not affect survival after 60 months of follow-up. TBIL >18.01 µmol/L increased the risk of mortality in pSS patients within 3-6 months (HR=2.30, 95% CI 1.42-3.79) but did not increase the risk of mortality in patients with pSS within 3 months of follow-up or after 60 months. Conclusion: pSS patients with a CRP level >6.5 mg/L have an 11-fold increased risk of near-term death, whereas pSS patients older than 65 years of age at diagnosis have a 16-fold increased risk of long-term death.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.